Professor PHILIP BATH philip.bath@nottingham.ac.uk
STROKE ASSOCIATION PROFESSOR OF STROKE MEDICINE
Testing devices for the prevention and treatment of stroke and its complications
Bath, Philip M.W.; Brainin, Michael; Brown, Chloe; Campbell, Bruce; Davis, Stephen M.; Donnan, Geoffrey A.; Ford, Gary A.; Hacke, Werner; Iglesias, Cynthia; Lees, Kennedy R.; Pugh, Stacey S.; Saver, Jeffrey L.; Schellinger, Peter D.; Truelsen, Thomas
Authors
Michael Brainin
Chloe Brown
Bruce Campbell
Stephen M. Davis
Geoffrey A. Donnan
Gary A. Ford
Werner Hacke
Cynthia Iglesias
Kennedy R. Lees
Stacey S. Pugh
Jeffrey L. Saver
Peter D. Schellinger
Thomas Truelsen
Abstract
We are entering a challenging but exciting period when many new interventions may appear for stroke based on the use of devices. Hopefully these will lead to improved outcomes at a cost that can be afforded in most parts of the world. Nevertheless, it is vital that lessons are learnt from failures in the development of pharmacological interventions (and from some early device studies), including inadequate preclinical testing, suboptimal trial design and analysis, and underpowered studies. The device industry is far more disparate than that seen for pharmaceuticals; companies are very variable in size and experience in stroke, and are developing interventions across a wide range of stroke treatment and prevention. It is vital that companies work together where sales and marketing are not involved, including in understanding basic stroke mechanisms, prospective systematic reviews, and education of physicians. Where possible, industry and academics should also work closely together to ensure trials are designed to be relevant to patient care and outcomes. Additionally, regulation of the device industry lags behind that for pharmaceuticals, and it is critical that new interventions are shown to be safe and effective rather than just feasible. Phase IV postmarketing surveillance studies will also be needed to ensure that devices are safe when used in the ‘real-world’ and to pick up uncommon adverse events.
Citation
Bath, P. M., Brainin, M., Brown, C., Campbell, B., Davis, S. M., Donnan, G. A., Ford, G. A., Hacke, W., Iglesias, C., Lees, K. R., Pugh, S. S., Saver, J. L., Schellinger, P. D., & Truelsen, T. (in press). Testing devices for the prevention and treatment of stroke and its complications. International Journal of Stroke, 9(6), https://doi.org/10.1111/ijs.12302
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 23, 2014 |
Online Publication Date | Jul 17, 2014 |
Deposit Date | Aug 17, 2016 |
Publicly Available Date | Aug 17, 2016 |
Journal | International Journal of Stroke |
Print ISSN | 1747-4930 |
Electronic ISSN | 1747-4949 |
Publisher | SAGE Publications |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Issue | 6 |
DOI | https://doi.org/10.1111/ijs.12302 |
Keywords | acute stroke therapy, clinical trial, device, prevention, stroke, treatment |
Public URL | https://nottingham-repository.worktribe.com/output/732256 |
Publisher URL | http://onlinelibrary.wiley.com/doi/10.1111/ijs.12302/abstract |
Contract Date | Aug 17, 2016 |
Files
BATH Testing devices.pdf
(3.9 Mb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search